Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Indonesia Pondasi Raya Tbk. (IDPR) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Indonesia Pondasi Raya Tbk.Trade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Indonesia Pondasi Raya Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Indonesia Pondasi Raya Tbk. trades at Rp278 (market cap 540.81B, 680.7K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp174 (market cap 691.25B, 635.5K 24h volume). The key difference: UBC Medical Indonesia Tbk. is the larger of the two by market cap, and Indonesia Pondasi Raya Tbk. is more actively traded (680.7K versus 635.5K). Which is the better fit depends on your goals.

IDPRLABS
Market Cap
540.81B691.25B
Volume
680.7K635.5K
Lot
6.81K6.36K
Turnover
198.43M110.15M
Average Price
291.51173.33
Value
198.43M110.15M
Indicative Equilibrium Price
286174
Indicative Equilibrium Volume
1050

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

IDPR
View details
LABS
View details

About Indonesia Pondasi Raya Tbk.

PT Indonesia Pondasi Raya Tbk (the Company) was established in Jakarta based on Notarial Deed Tan Thong Kie No. 18 dated 21 October 1977 and has been approved by the Ministry of Law in its decision letter No. Y.A 5/118/24 and was published in Supplement No. 430 of the State Gazette No. 49 dated 17 June 1980.

Read more on IDPR

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS